Category VC / PE

HIP2 is a programme designed for Malaysian SMEs to help them seamlessly move their innovations along the complex stages of the commercialisation process. It is about ‘Innovating A Better Future Together’.

The implementation of High Impact Programme 2 (HIP2) – Technology Commercialisation Platform (TCP) under one of the size High Impact Programmers of SME Masterplan 2012 – 2020 is a strategic partnership between SME Corporation Malaysia (SME Corp) and Agensi Inovasi Malaysia (AIM). PlaTCOM Ventures Sdn Bhd is the public-private partnership under which this programme is implemented.

The model addresses the innovation gaps through a holistic and ‘market-driven’ approach in supporting innovation and industrial competitiveness. It is designed to remove market and financing barriers to innovation. The major benefits of this innovative commercialisation model will be de-risking the risks involved for SMEs to develop products and services with lower costs and faster time-to-market, leveraging on trusted technologies from across Malaysia and overseas and receiving technology transfer and commercialisation support to further develop innovations.

The programme provides necessary support from ‘concept to commercialisation’. This is done through the provision of access to technical assistance, market intelligence, incubation facilities, testing facilities and other relevant services – all in a single platform.

Benefits for SMEs

The programme will provide complete support from ‘concept to commercialisation’. This will be done through the provision of access to technical assistance, market information, incubation facilities, testing facilities and other relevant services and linkages necessary for SMEs to move their innovations to the market.

• The programme is about de-risking the risks involved in SMEs to develop products and services with lower costs and faster time to market
• SMEs can leverage on trusted technologies from across Malaysia and overseas
• Technology transfer and commercialisation support to further develop innovations
• We provide necessary support from ‘concept to commercialisation’ through the provision of access to technical assistance, market intelligence, incubation facilities, testing facilities, and other relevant services – all in a single platform
• We assist by removing market and financial barriers

Eligibility Criteria for Admission into the HIP2 Programme to Receive End-to-End Facilitation

If you think you are HIP2 material by meeting the following criteria, speak to us today:

• Must be an SME with a minimum of 51% equity held by Malaysian Citizen/s
• The company must have a minimum paid up capital of RM10,000
• None of the company directors or project team members have been convicted of any fraudulent activities or the company been declared bankrupt, under liquidation or placed under receivership
• The proposed project must contain elements of technological innovation leading to commercialisation of innovative products, processes and services
• There is no restriction as to where the proposed project is in the commercialisation process; however, it must be demonstrated that the innovation has stalled due to a number of barriers
• The project leader and team members must be competent to undertake the proposed project

Overview
– Asia’s leading specialist healthcare private equity firm
– 3 private equity vehicles since 2008
– 15 investments across 6 countries
– Over US$1.5bn in managed capital

Value add
– Industry knowledge, experience and relationships
– Patient, selective approach to partnerships
– Dedicated team to address company needs and drive value creation
– Regional and global connectivity to unlock growth opportunities
– Long-term alignment and management stability
– Works closely with management to clearly define and execute on growth plans